Highlights of Gene and Cell Therapy for Epidermolysis Bullosa and Ichthyosis

    August 2024 in “ Dermatology and Therapy ”
    S.A. Koutsoukos, Ganna Bilousova
    Studysummary This review highlights preclinical and clinical advancements in gene and cell therapies for epidermolysis bullosa and ichthyosis, noting a recently FDA-approved gene therapy for recessive dystrophic EB.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Inflammatory Vegetative Lesions of the Perineum: A Rare and Severe Clinical Presentation of Netherton Syndrome Acta Dermato Venereologica · 2020

    Related research 1

    1. Early Diagnosis of Ichthyosis, Leukocyte Vacuoles, Alopecia, and Sclerosing Cholangitis Syndrome: A Case Report Pediatric Dermatology · 2023